Vial, syringe and cartridge flexibility in a standardized machine? Sure.
The sterility assurance of a completely closed, gloveless robotic isolator? Vanrx invented it.
Transform your contract fill-finish operations with the Aseptic Filling Workcell and bring amazing drug products to patients.
CDMOs including Singota Solutions, FUJIFILM Diosynth, and WuXi Biologics have chosen Vanrx to flexibly serve clients who are making biologics, peptides, gene therapies and other drug product modalities.
Vanrx customers typically complete their validation 12-15 months from their purchase order for an SA25 and 6 months for the Microcell. In the CDMO fill-finish space, WuXi reached their first GMP batch release in 15 months and had 7 different container formats validated in that period. That’s a typical timeline for our Aseptic Filling Workcells.
Every CDMO wants to drive up its utilization rate. Vials, syringes, cartridges–if it’s nested and pre-sterilized, our machines can fill it. You can change over between formats in an hour or less and our decontamination cycles take less time than that. With Vanrx, you have what you need to drive the rate up.
When you choose Vanrx, you get technology for drug product quality that only we can offer. A fully closed gloveless isolator that gets humans out of the aseptic process. Robotics and automation programming drive repeatable processes that increase drug product quality.
Aseptic Filling Workcells have small footprints and require only a Grade C background, so you can have a smaller, less expensive cleanroom to house a machine. They have simple utility requirements too–just power, compressed air and an exhaust. You’ll also use fewer operators and have lower energy consumption.